HKSE - Delayed Quote HKD
Immunotech Biopharm Ltd (6978.HK)
4.150
+0.080
+(1.97%)
At close: April 25 at 3:57:29 PM GMT+8
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-163,629
-163,629
-180,922
-254,653
-263,665
Investing Cash Flow
-116,597
-116,597
23,381
-328,206
-204,067
Financing Cash Flow
273,922
273,922
-36,060
-10,999
1,054,688
End Cash Position
52,161
52,161
58,448
251,401
845,386
Capital Expenditure
-22,539
-22,539
-96,567
-181,239
-75,672
Issuance of Capital Stock
--
--
--
--
1,137,111
Issuance of Debt
300,000
300,000
1,000
--
--
Repayment of Debt
-1,000
-1,000
--
--
--
Free Cash Flow
-186,168
-186,168
-277,489
-435,892
-339,337
12/31/2020 - 7/10/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
6660.HK AIM Vaccine Co., Ltd.
3.290
-2.95%
1877.HK JUNSHI BIO
15.420
-3.50%
9966.HK Alphamab Oncology
6.910
-0.43%
2137.HK Brii Biosciences Limited
2.000
+8.11%
9969.HK InnoCare Pharma Limited
10.140
-3.61%
1952.HK Everest Medicines Limited
47.400
+2.16%
9688.HK Zai Lab Limited
25.650
-1.16%
1801.HK INNOVENT BIO
54.350
-1.09%
1177.HK SINO BIOPHARM
3.950
+1.54%
9926.HK Akeso, Inc.
98.900
-1.10%